Literature DB >> 902437

Accelerated mortality in young NZB/NZW mice treated with the interferon inducer tilorone hydrochloride.

S E Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 902437     DOI： 10.1016/0090-1229(77)90110-6

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  5 in total

1.  Interferon treatment of NZB mice: accelerated progression of autoimmune disease.

Authors:  H Heremans; A Billiau; A Colombatti; J Hilgers; P de Somer
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice.

Authors:  C Adam; Y Thoua; P Ronco; P Verroust; M Tovey; L Morel-Maroger
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

Review 3.  New roles for the major human 3'-5' exonuclease TREX1 in human disease.

Authors:  David Kavanagh; Dirk Spitzer; Parul H Kothari; Aisha Shaikh; M Kathryn Liszewski; Anna Richards; John P Atkinson
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

4.  Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon.

Authors:  D Sergiescu; I Cerutti; A Kahan; D Piatier; E Efthymiou
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

5.  Stimulated autoantibody response and increased longevity in NZB/NZW mice treated with cyclophosphamide and tilorone.

Authors:  S E Walker; M R Anver
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.